Updated Jul 16, 2026
GOLL JOHN is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $23K.
John Goll is an executive associated with Immunocore Holdings plc, a biotechnology company focused on developing therapies for cancer and other serious diseases. He has been involved in various roles within the company, contributing to its strategic direction and operational management.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-19 | IMCR | Immunocore Holdings plc | S — Open-market sale | 698 | $32.35 | $23K |
| 2026-02-19 | IMCR | Immunocore Holdings plc | M — Option exercise | 1.4K | $0.00 |
John Goll is an executive associated with Immunocore Holdings plc, a biotechnology company focused on developing therapies for cancer and other serious diseases. He has been involved in various roles within the company, contributing to its strategic direction and operational management.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($23K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GOLL JOHN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.